
Eyoto Appoints Tony Veverka as Interim CEO, Looks to Expand U.S. Presence
Published on April 24, 2026
BIRMINGHAM, U.K.—Eyoto, a medtech company focusing on teleoptometry, announced it has named Tony Veverka as its new interim CEO. Veverka has served as a board advisor for Eyoto since 2025 and according to the company he brings extensive experience in the medtech and health care industries to the role. Veverka has held senior leadership roles in both the U.K. and U.S. He began his career at Bupa, an international health care company, then led Ultralase Eye Clinics as CEO during its growth in the early 2000s, the announcement said.
